Update on the genetics of allergic diseases. Journal of Allergy and Clinical Immunology. 2025; 155(6):1738-1752.
Massively Parallel Analysis of Genotype-Dependent Enhancer Activity Among Atopic Dermatitis Genetic Risk Variants. . 2024.
Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024; 9(9).
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. BMC Genomics. 2024; 25(1):273.
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis. American Journal of Human Genetics. 2024; 111(2):280-294.
Multiancestral polygenic risk score for pediatric asthma. Journal of Allergy and Clinical Immunology. 2022; 150(5):1086-1096.
Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis. PLoS Genetics. 2022; 18(5):e1009973.
Epstein-Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci. Genome Research. 2021; 31(12):2185-2198.
Runx1 shapes the chromatin landscape via a cascade of direct and indirect targets. PLoS Genetics. 2021; 17(6):e1009574.
Global discovery of lupus genetic risk variant allelic enhancer activity. Nature Communications. 2021; 12(1):1611.
Global discovery of lupus genetic risk variant allelic enhancer activity. Nature Communications. 2021; 12(1).
Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes. Journal of Allergy and Clinical Immunology. 2021; 147(1):255-266.
Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nature Genetics. 2018; 50(5):699-707.
Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. New England Journal of Medicine. 2017; 377(12):1156-1167.
Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 2017; 8:16021.
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nature Genetics. 2014; 46(8):895-900.
Immune pathways and prenatal/perinatal environmental exposures contribute to epigenetic gestational age prediction and acceleration. Epigenetics. 2026; 21(1):2610521.
The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments. American Journal of Human Genetics. 2026.
Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study. American Journal of Human Genetics. 2026.
Multi-trait Analysis of GWAS Expands Eosinophilic Esophagitis Genetic Susceptibility and Polygenic Risk Scores. Journal of Allergy and Clinical Immunology. 2026.
Gene regulatory network determinants of rapid recall in human memory CD4+ T cells. Cell reports. 2026; 45(4):117103.
Sequencing and health data resource of children of African ancestry. Genetics in Medicine. 2026; 28(3):101660.
B-Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization. Allergy. European Journal of Allergy and Clinical Immunology. 2026; 81(2):513-523.
Single cell atlas of lung-resident innate lymphoid cells shows impact of age and dysbiosis on epigenetic and transcriptomic programming. Mucosal Immunology. 2026.
Polygenic risk score and phenome-wide association study of the Epstein-Barr virus antibody response. Frontiers in Genetics. 2026; 17:1786510.
Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants. Journal of Allergy and Clinical Immunology. 2025; 156(6):1600-1613.
Genome-wide cross-trait analysis of heterogeneous outcomes in early life atopic dermatitis. Pediatric Allergy and Immunology. 2025; 36(12):e70253.
Genome-wide discovery of multiple sclerosis genetic risk variant allelic regulatory activity. G3: Genes, Genomes, Genetics. 2025; 15(11).
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice. Journal of Clinical Investigation. 2025; 135(21).
Erythroid-specific, inducible CDAN1∆/∆ mouse model phenocopies congenital dyserythropoietic anemia type-la. Blood. 2025; 146(Supplement 1):186-186.
Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells. American Journal of Transplantation. 2025; 25(11):2345-2360.
Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics study. JAMIA Open. 2025; 8(5):ooaf113.
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activity. eLife. 2025; 13.
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activity. eLife. 2025; 13.
Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics. Pharmacotherapy. 2025; 45(8):476-485.
Phenome-wide association study identifies multiple traits associated with a polygenic risk score for colorectal cancer. Human Genomics. 2025; 19(1):77.
A survey of pathogenic involvement in non-communicable human diseases. Communications Medicine. 2025; 5(1):242.
Update on the genetics of allergic diseases. Journal of Allergy and Clinical Immunology. 2025; 155(6):1738-1752.
GDF10 promotes rodent cardiomyocyte maturation during the postnatal period. Journal of Molecular and Cellular Cardiology. 2025; 201:16-31.
Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups. Nature Communications. 2025; 16(1):2273.
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia. Blood advances. 2025; 9(4):856-861.
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science. 2025; 387(6734):eadp4753.
Risk factors affecting polygenic score performance across diverse cohorts. eLife. 2025; 12.
Silencing TET1 expression alters the epigenomic landscape and amplifies transcriptomic responses to allergen in airway epithelial cells. Environmental Epigenetics. 2025; 11(1):dvaf007.
Genome-wide epigenetic profiling and transcriptome analysis in pediatric Obstructive Sleep Apnea: A focus on Black female children. Heliyon. 2024; 10(23):e40830.
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting. Journal of Allergy and Clinical Immunology. 2024; 154(4):882-892.
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 2024; 76(10):1566-1572.
Massively Parallel Analysis of Genotype-Dependent Enhancer Activity Among Atopic Dermatitis Genetic Risk Variants. . 2024.
A deep catalogue of protein-coding variation in 983,578 individuals. Nature. 2024; 631(8021):583-592.
Variant level heritability estimates of type 2 diabetes in African Americans. Scientific Reports. 2024; 14(1):14009.
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network. American Journal of Human Genetics. 2024; 111(6):999-1005.
Macrophage memories of early-life injury drive neonatal nociceptive priming. Cell reports. 2024; 43(5):114129.
Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024; 9(9).
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. BMC Genomics. 2024; 25(1):273.
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nature Medicine. 2024; 30(2):480-487.
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis. American Journal of Human Genetics. 2024; 111(2):280-294.
The transcription factor ZEB2 drives the formation of age-associated B cells. Science. 2024; 383(6681):413-421.
Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting. Journal of Allergy and Clinical Immunology. 2023; 152(6):1382-1393.
Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells. Cell reports. 2023; 42(10):113180.
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Nature Communications. 2023; 14(1):6030.
A functional mechanism for a non-coding variant near AGTR2 associated with risk for preterm birth. BMC Medicine. 2023; 21(1):258.
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nature Genetics. 2023; 55(7):1091-1105.
Utilization of electronic health record data to evaluate the association of urban environment with systemic lupus erythematosus symptoms. Rheumatology. 2023; 62(6):e180-e181.
Genome-wide admixture and association analysis identifies African ancestry-specific risk loci of eosinophilic esophagitis in African Americans. Journal of Allergy and Clinical Immunology. 2023; 151(5):1337-1350.
Returning integrated genomic risk and clinical recommendations: The eMERGE study. Genetics in Medicine. 2023; 25(4):100006.
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nature Communications. 2023; 14(1):1598.
Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female-Specific Health Conditions. Journal of the American Heart Association. 2023; 12(5):e026561.
Gene-environment interactions and their impact on human health. Genes and Immunity. 2023; 24(1):1-11.
Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index. Pacific Symposium on Biocomputing. 2023; 28:437-448.
maxATAC: Genome-scale transcription-factor binding prediction from ATAC-seq with deep neural networks. PLoS Computational Biology. 2023; 19(1):e1010863.
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nature Communications. 2022; 13(1):6914.
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits. Nature Communications. 2022; 13(1):6859.
Multiancestral polygenic risk score for pediatric asthma. Journal of Allergy and Clinical Immunology. 2022; 150(5):1086-1096.
Frontotemporal degeneration genetic risk loci and transcription regulation as a possible mechanistic link to disease risk. Medicine (United Kingdom). 2022; 101(41):e31078.
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. Genome Medicine. 2022; 14(1):70.
Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis. PLoS Genetics. 2022; 18(5):e1009973.
Enrichment of Epstein Barr Virus in patients with Multiple Sclerosis. Journal of Immunology. 2022; 208(Supplement_1):104.09-104.09.
Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. Nature Communications. 2022; 13(1):1855.
Inference of causal relationships between genetic risk factors for cardiometabolic phenotypes and female-specific health conditions. Res Sq. 2022.
CASCADE: high-throughput characterization of regulatory complex binding altered by non-coding variants. Cell Genomics. 2022; 2(2).